Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drugFirst approved 2023

Zepbound(Tirzepatide)Eli Lilly and Company logoLLY

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Eli Lilly and Company

$387K

Medicare cost, 2024

Medicare drug plans spent $387,343 on Zepbound (tirzepatide) in 2024, for 353 prescriptions and refills filled by 245 patients. It was first approved in 2023. Rhode Island accounts for the most spending ($95,460, 25% of the total). It is made by Eli Lilly and Company (LLY).

Medicare cost, 2024

$387K

Prescriptions

353

$1,097.29 per claim

Patients

245

250 prescribers

Total spending, 2024

$387K

$1,580.99 per patient

Questions and answers

How much does Medicare spend on Zepbound?

Medicare prescription drug plans paid $387K for Zepbound in 2024, for 353 prescriptions and refills to 245 patients. The average cost per claim was $1,097.29.

Which state spends the most on Zepbound?

Rhode Island had the highest Medicare cost for Zepbound in 2024: $95K for 93 claims, followed by Florida ($29K).

Who prescribes Zepbound the most?

Meghan K Carides, nurse practitioner in Providence, RI, had the highest Medicare cost for Zepbound in 2024: 14 claims costing $14K.

Who makes Zepbound?

Zepbound is made by Eli Lilly and Company (LLY), listed in the Medicare spending data as Eli Lilly & Co..

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Zepbound, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Meghan K Carides Providence, RINurse Practitioner14Under 11$14K

Prescriber data by year

YearPrescribersClaimsPatientsCost
2024250353245$387K

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Eli Lilly & Co.LLY logoLLY353$387K

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
26
RxNorm concept IDs
2601743, 2601755, 2601761, 2601767, 2601773
Application numbers
NDA217806

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube